Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

Not Recruiting

Trial ID: NCT00628199


This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Official Title

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming

Stanford Investigator(s)


Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)

Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.


procedure: Improving the scientific process of human cell reprogramming

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305